Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cafbc364519a81efe3bec9748580f54f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4af544b6d98f9440b855264fe1ccb33 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38 |
filingDate |
2005-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30014bd448bd7292f2de1596c3936e66 |
publicationDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005102382-A1 |
titleOfInvention |
Use of hamlet (human alpha-lactalbumin made lethal to tumour cells) for treating viral infections |
abstract |
The use of a biologically active complex of a-lactalbumin, selected from HAMLET (human (x-lactalbumin made lethal to tumour cells) or a biologically active modification thereof, or a biologically active fragment of either of these, in the preparation of a medicament for use in the treatment of viral infections. |
priorityDate |
2004-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |